Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Dose-Response Relationship Study of SR141716 in Obese Patients
NCT00459004Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rimonabant in obesity, sponsored by Sanofi. Started Oct 2004; status: completed.
02
Drugs
rimonabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00459004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459004.